Two large U.S.-based drug companies – AbbVie and Eli Lilly – have now exited the voluntary drug price agreement, citing the “punitive” system of revenue clawbacks, which has risen to 26.5% of branded sales in 2022. And, AbbVie and Lilly aren’t the only…
The Federal Bureau of Investigation on Thursday began offering rewards of up to $25,000 for information about a series of attacks on at least 10 reproductive health care facilities across the U.S. last year.
Some studies suggest the drug, which has been decriminalized in some states but remains illegal federally, could provide benefits to people suffering from mental health conditions.
Here are some insights gleaned from Dr. Jim O’Connell, president of Boston Health Care for the Homeless Program and Tracy Kidder, whose book describing the years he embedded with the Boston street team, “Rough Sleepers,” was just published.
Fewer than one-third of the most commonly advertised drugs were rated as having “high therapeutic value,” defined as providing at least moderate improvement in clinical outcomes relative to existing treatment alternatives.